Rchr
J-GLOBAL ID:202301003450112515   Update date: Nov. 16, 2024

Rai Kammei

Rai Kammei
Research theme for competitive and other funds  (2):
  • 2021 - 2024 Evaluation of exercise tolerance with low-intensity exercise using wearable devices
  • 2016 - 2019 Overcome resistance against EGFR molecular targeting drugs by siRNA
Papers (42):
  • Taichi Ozeki, Hisao Higo, Hiroki Omori, Shunta Mori, Shin Tanaka, Go Makimoto, Kiichiro Ninomiya, Akihiko Taniguchi, Masanori Fujii, Kentaro Miyoshi, et al. A Case of Single-lung Transplant in a Patient with Mycobacterium avium Pulmonary Disease Successfully Treated with Amikacin Liposome Inhalation Suspension. Internal medicine (Tokyo, Japan). 2024
  • Hiroaki Matsuura, Hisao Higo, Tadahiro Kuribayashi, Akihiko Tamaoki, Takamasa Nakasuka, Mari Uno, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, et al. Concomitant osimertinib and antituberculosis therapy in an elderly patient with EGFR-mutated lung cancer and pulmonary tuberculosis: A case report. Thoracic cancer. 2024. 15. 17. 1390-1394
  • 宇野 真梨, 槇本 剛, 藤 智和, 大森 洋樹, 肥後 寿夫, 本倉 優美, 田中 孝明, 森 俊太, 大西 桐子, 二宮 貴一朗, et al. 肝切除後の難治性気管支胆汁瘻に対してEndobronchial Watanabe Spigotの挿入が感染制御に有効であった1例. 気管支学. 2024. 46. Suppl. S337-S337
  • Masahiro Yamashita, Hisao Higo, Nobuharu Fujii, Chiaki Matsumoto, Go Makimoto, Kiichiro Ninomiya, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, et al. Protracted coronavirus disease 2019 after chimeric antigen receptor-T cell therapy successfully treated with sequential multidrug therapy. Respiratory medicine case reports. 2024. 51. 102104-102104
  • Takumi Kishimoto, Kenzo Okamoto, Shigeki Koda, Mariko Ono, Yumi Umeda, Shotaro Yamano, Tomoki Takeda, Kammei Rai, Katsuya Kato, Yasumitsu Nishimura, et al. Respiratory disease in workers handling cross-linked water-soluble acrylic acid polymer. PloS one. 2023. 18. 4. e0284837
more...
MISC (69):
  • 久保 寿夫, 中須賀 崇匡, 谷口 暁彦, 二宮 貴一朗, 大橋 圭明, 頼 冠名, 堀田 勝幸, 宮原 信明, 田端 雅弘, 木浦 勝行. 災害ボランティア後にアスペルギローマとアレルギー性気管支肺アスペルギルス症を合併した一例. 気管支学. 2021. 43. Suppl. S284-S284
  • 大橋 圭明, 大川 祥, 頼 冠名, 木浦 勝行. 気管支鏡下再生検にて診断しえたIgG4関連疾患におけるEGFR変異肺腺癌合併の一例. 気管支学. 2021. 43. Suppl. S297-S297
  • Yuka Kato, Taku Noumi, Kazuhiko Saeki, Kiichiro Ninomiya, Toshio Kubo, Masanori Fujii, Kammei Rai, Eiki Ichihara, Kadoaki Ohashi, Masahiro Tabata, et al. Impact on second-line treatment after failure of immune checkpoint inhibitor (ICI) combination chemotherapy in extensive-disease small cell lung cancer: Experience of the Okayama Lung Cancer Study Group. JOURNAL OF CLINICAL ONCOLOGY. 2021. 39. 15
  • 中須賀 崇匡, 大橋 圭明, 西井 和也, 平生 敦子, 大川 祥, 安東 千裕, 原 尚史, 狩野 裕久, 渡邉 洋美, 二宮 貴一朗, et al. Egfr改変肺癌マウスモデルを用いたAd-SGE-REICの抗腫瘍効果の検討. 肺癌. 2020. 60. 6. 528-528
  • 狩野 裕久, 市原 英基, 大川 祥, 平生 敦子, 安東 千裕, 中須賀 崇匡, 原 尚史, 西井 和也, 渡邉 洋美, 二宮 貴一朗, et al. SHP2阻害剤は遺伝子変異陽性肺癌細胞株における分子標的薬の効果を増強する. 肺癌. 2020. 60. 6. 529-529
more...
Professional career (1):
  • M.D.,Ph.D. (Okayama University)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page